SILKSilk Road Medical Inc

Nasdaq silkroadmed.com


$ 17.83 $ 0.15 (0.85 %)    

Friday, 26-Apr-2024 15:59:54 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 17.8
$ 17.44
$ 0.00 x 0
$ 0.00 x 0
$ 17.44 - $ 18.14
$ 6.08 - $ 45.09
449,136
na
690.72M
$ 1.49
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-02-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-earlier-genesis-medtech-collaborates-with-silk-road-medical-to-combat-stroke-risk-in-china-with-advanced-tcar-technology

TCAR (Transcarotid Artery Revascularization) is an innovative minimally invasive surgical procedure used to treat carotid arter...

 argus-research-upgrades-silk-road-medical-to-buy-announces-24-price-target

Argus Research analyst Steve Silver upgrades Silk Road Medical (NASDAQ:SILK) from Hold to Buy and announces $24 price target.

 stifel-maintains-buy-on-silk-road-medical-raises-price-target-to-23

Stifel analyst Rick Wise maintains Silk Road Medical (NASDAQ:SILK) with a Buy and raises the price target from $20 to $23.

 jp-morgan-maintains-neutral-on-silk-road-medical-raises-price-target-to-19

JP Morgan analyst Robbie Marcus maintains Silk Road Medical (NASDAQ:SILK) with a Neutral and raises the price target from $1...

 top-3-health-care-stocks-you-may-want-to-dump-in-q1

As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as...

 piper-sandler-maintains-neutral-on-silk-road-medical-raises-price-target-to-18

Piper Sandler analyst Adam Maeder maintains Silk Road Medical (NASDAQ:SILK) with a Neutral and raises the price target from ...

 silk-road-medical-q4-2023-gaap-eps-033-beats-042-estimate-sales-4727m-beat-4197m-estimate

Silk Road Medical (NASDAQ:SILK) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 heart-devices-focused-silk-road-medical-stock-gets-an-upgrade---analyst-says-new-ceos-initiatives-sets-stage-for-back-on-track

Stifel's upgraded outlook on Silk Road Medical as CEO Chas McKhann addresses concerns, unveils a compelling vision, and out...

 why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

 world-acceptance-posts-upbeat-earnings-joins-kaman-spirit-airlines-and-other-big-stocks-moving-higher-on-friday

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporatio...

 texas-instruments-to-rally-around-17-here-are-10-top-analyst-forecasts-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 stifel-upgrades-silk-road-medical-to-buy-raises-price-target-to-20

Stifel analyst Rick Wise upgrades Silk Road Medical (NASDAQ:SILK) from Hold to Buy and raises the price target from $9 to $20.

 why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION